Multiomic nanopore sequencing: revolutionising human disease research


Overview

Resolving the mechanisms underpinning human diseases is vital to understanding disease phenotypes, identifying novel biomarkers, and enabling drug discovery. Multiomic approaches that cover genomics, transcriptomics, epigenomics, and proteomics are crucial to this and provide data to unravel complex pathways and maximise invaluable research samples.

In this brochure, find out how multiomic nanopore sequencing can accelerate your disease research — all on a single platform with flexible and fast nanopore sequencing workflows to provide informative results in short turnaround times